Furthermore, aliskiren, a direct renin inhibitor, was shown to limit atherosclerosis and AAA in an Ang II-infused mouse model by reducing prorenin receptor expression and Mitogen-activated protein kinases activity (Seto et al., 2014; Miyake et al., 2017). Here, WNK2 is linked to triple-A syndrome.